Abstract:BACKGROUND Gastric cardia adenocarcinoma (GCA), which has been classified as type II adenocarcinoma of the esophagogastric junction in western countries, is of similar geographic distribution with esophageal squamous cell carcinoma in China, and even referred as "sister cancer" by Chinese oncologists. The molecular mechanism for GCA is largely unknown. Recent studies have shown that decreased expression of E-cadherin is associated with the invasion and metastasis of multiple cancers. However, the E-cadherin expression has not been well characterized in gastric cardia carcinogenesis and its effect on GCA prognosis. AIM To characterize E-cadherin expression in normal gastric cardia mucosa, dysplasia and GCA tissues, and its influence on prognosis for GCA. METHODS A total of 4561 patients with GCA were enrolled from our previously established GCA and esophageal cancer databases. The enrollment criteria included radical surgery for GCA, but without any radio- or chemo-therapy before operation. The GCA tissue from 4561 patients and matched adjacent normal epithelial tissue (n = 208) and dysplasia lesions (n = 156) were collected, and processed as tissue microarray for immunohistochemistry. The clinicopathological characteristics were retrieved from the medical records in hospital and follow-up was carried out through letter, telephone or home interview. E-cadherin protein expression was determined by two step immunohistochemistry. Kaplan-Meier and Cox regression analyses were used to correlate E-cadherin protein expression with survival of GCA patients RESULTS Of the 4561 GCA patients, there were 3607 males with a mean age of 61.6 8.8 and 954 females with a mean age of 61.9 +/- 8.6 years, respectively. With the lesions progressed from normal gastric cardia mucosa to dysplasia and GCA, the positive immunostaining rates for E-cadherin decreased significantly from 100% to 93.0% and 84.1%, respectively (R-2 = 0.9948). Furthermore, E-cadherin positive immunostaining rate was significantly higher in patients at early stage (0 and I) than in those at late stage (II and III) (92.7% vs 83.7%, P = 0.001). E-cadherin positive expression rate was significantly associated with degree of differentiation (P = 0.001) and invasion depth (P < 0.001). Multivariate analysis showed that the GCA patients with positive E-cadherin immunostaining had better survival than those with negative (P = 0.026). It was noteworthy that E-cadherin positive expression rate was similar in patients with positive and negative lymph node metastasis. However, in patients with negative lymph node metastasis, those with positive expression of E-cadherin had better survival than those with negative expression (P = 0.036). Similarly, in patients with late stage GCA, those with positive expression of E-cadherin had better survival than those with negative expression (P = 0.011). CONCLUSION E-cadherin expression may be involved in gastric cardia carcinogenesis and low expression of E-cadherin may be a promising early biomarker and overall survival predictor for GCA.

Expression and Significance of E-Cadherin and Matrix Metalloproteinase-9 in Gastric Carcinoma

Expressions of MMP-9 and PEDF and Their Correlation with Tumor Invasion and Lymph Node Metastasis in Gastric Carcinoma

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

Expression and Significance of VEGF and MMP-9 in Gastric Carcinoma

Expression and Significance of Annexin A2 in Patients with Gastric Adenocarcinoma and the Association with E-cadherin.

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]

The Significance of TDGF-1 Expression in Gastric Cancer and Its Role in Epithelial-mesenchymal Transition

Expression and clinical significance of GS,E-cadherin and β-catenin in hepatocellular carcinoma

Expression of Ezrin and CD44v6 and Their Clinical Significance in Gastric Carcinoma

[Expression and Significance of CD147 and E-cadherin in Human Gastric Carcinoma].

Expression of E-cadherin, β-catenin, MMP-7 and their significances in cholangiocarcinoma

Expressions of VEGF-D and MMP-7 in Gastric Cancer and Their Relationship with Prognosis

Relationship of MMP-2mRNA Expression with Clinical Pathological Features and Prognosis in Gastric Cancer

Expression of extracellular matrix metalloproteinase inducer CD147 and MMP-9 in hepatocellular carcinoma and its clinical significance

Expression and corelation of activated c-Src protein tyrosine kinase, HER2 and Ki-67 in gastric cancer

The relationship between the expression of EphA1 in gastric carcinoma, metastasis and survival

Expression of MMP-26 and MMP-7 in Gastric Adenocarcinoma and Its Clinicopathological Significance

Expression and clinical significance of VEGF and markers of EMT in gastric cancer

Characterization of E-cadherin Expression in Normal Mucosa, Dysplasia and Adenocarcinoma of Gastric Cardia and Its Influence on Prognosis

Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer

Clinical Significance of Matrix Metalloproteinase-9 Expression in Esophageal Squamous Cell Carcinoma.